Endotronix presented positive six-month results from its PROACTIVE-HF pivotal trial of the investigational Cordella Pulmonary Artery (PA) Sensor on March 5. The trial, in New York Heart Association ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted premarket approval to Endotronix’s pulmonary artery sensor platform for remote management of ...

Endotronix has secured an FDA approval for its early warning sensor implant to remotely track patients with serious and potentially worsening heart failure. The minimally invasive Cordella system ...

Please provide your email address to receive an email when new articles are posted on . A novel stick-on monitor could reduce HF readmissions by 7% vs. controls. The number needed to treat to avoid ...

Add Yahoo as a preferred source to see more of our stories on Google. Abbott's CardioMEMS cardiac sensor will now be available to patients with chronic heart failure through the NHS. Image credit: ...

It’s been part of Bill Keiss daily routine for nearly a year. “I get up in the morning and I take all my vitals,” Keiss, 71, said. Stream NBC 5 for free, 24/7, wherever you are. Suffering from ...

CardioMEMS, which develops wireless, implantable medical sensors, announced a new $37.9 million round of venture capital investment. That brings the company's total raised capital amount to about $145 ...

Cordella, which consists of the now PMA-approved Cordella PA Sensor and commercial Cordella™ HF System, enables comprehensive heart failure management in the home using pulmonary artery (PA) pressure, ...

(RTTNews) - Abbott (ABT) said data from an investigator-sponsored European trial found managing indicated heart failure patients with CardioMEMS HF System resulted in a significant improvement in ...

Endotronix Inc. reported positive data from the SIRONA 2 clinical trial evaluating safety and efficacy of its Cordella pulmonary artery pressure sensor system in New York Heart Association (NYHA) ...

The National Institute for Health and Care Excellence (NICE) has recommended the CardioMEMS HF System (Abbott) for routine use in England for adults with chronic heart failure at risk for hospital ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...